Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

8.21
Delayed Data
As of May 27
 +0.18 / +2.24%
Today’s Change
4.37
Today|||52-Week Range
10.07
+31.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.5B

Company Description

ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. Its products include Iclusig and Caregivers. The company was founded by Harvey J. Berger in April 1991 and is headquartered in Cambridge, MA.

Contact Information

ARIAD Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge Massachusetts 02139-4234
P:(617) 494-0400
Investor Relations:
(617) 621-2208

Employees

Shareholders

Other institutional42.05%
Mutual fund holders31.67%
Individual stakeholders10.90%

Top Executives

Paris PanayiotopoulosPresident, Chief Executive Officer & Director
Manmeet Singh SoniChief Financial Officer, Treasurer & Executive VP
Timothy P. ClacksonChief Scientific Officer
Frank G. HaluskaChief Medical Officer
Nicholas VentrescaChief Information Officer & Senior Vice President